Organic Chemistry TRIZ Cases

FAP targeting can cause toxicity in non-tumor cells; bicyclic heteroaromatic compounds instead inhibit NNMT to target CAFs and reduce tumor burden.

Hydrophilic protonic ionic liquids replace water reservoirs, enabling smaller electrochemical gas sensors with stable high-voltage sensitivity.

A tablet composition uses salt form and excipient phases to raise dose, improve bioavailability, and maintain dissolution at higher pH.

Nucleic acid fluorophore complexes map lysosomal pH with Ca²⁺ or Cl⁻ at single-endosome resolution in live cells.

Selective NLRP3 inhibition uses fused pyridazine aryl compounds to modulate NF-κB signaling and reduce excessive inflammatory responses.

Bio-based itaconate oligomers and branched glycidyl ester diluents enable UV-cured coatings with strong adhesion, durability, and lower health risks.

Selective naphthylamide inhibition of Aurora B over VEGFR improves tumor therapy, lowers hypertension risk, and enables brain exposure.

Sulfonamide-based probes selectively react with nitric oxide to form stable luminescent reporters, reducing false positives in quantitative assays.

A fused-ring and hetero-ring host blend improves OLED color purity, emission efficiency, and lifetime while supporting low-voltage operation.

N-containing cyclic groups in a nitrile-bearing compound improve electron mobility, lower OLED driving voltage, and extend service life.

A dispersion-assisted tubular reactor combines washing, impurity transfer, and neutralization to purify nitroaromatics with less complexity and water.

Multiple phenolic compounds prevent sebum and oil oxidation on fabrics, reducing malodor at lower concentrations with improved stability.

Part of the column-kettle stream enters a purifier that removes heavy impurities, improving extractant purity and epoxyalkane yield.

Weak chelators lose metal ions during washing; modified soluble chelators retain His-tagged protein binding despite EDTA and DTT.

A naphthyl-phenyl linker and 2-carbazolyl group improve hole transport mobility and stability in organic light-emitting devices.

Rad51-BRCA2 disruptors extend synthetic-lethal cancer treatment beyond BRCA-mutated tumors and sensitize cells to PARP inhibitors.

Azide–polymer crosslinking forms wet-processable functional layers that improve flexibility and performance in light-emitting elements.

Covalent bonding at cysteine 727 gives WRN helicase inhibitors a defined mechanism for targeting MSI-H cancer.

Cyclohexyl-substituted organic compounds reduce refractive-index losses while retaining carrier transport for higher EL outcoupling efficiency.

Two-stage pH adjustment and crystallization recover high-purity aromatic diol crystals from polycarbonate resin without distillation.

HCl and HBr crystalline or amorphous salts address Compound A’s solubility and formulation-stability limits for C5aR therapy.

Specific host compounds and polycyclic dopants reduce electrochemical load on emitters for efficient, durable blue organic EL operation.

Antioxidants limit oxidative impurities in oral OAD2 compositions, while solubilizing and disintegrating agents support dissolution during normal storage.

Narrow-band organic molecules deliver high photoluminescence quantum yields for purer, more stable OLED emission.

Partially saturated cyclohexene compounds deliver powerful, long-lasting muguet notes with clean diffusion and low odour thresholds for perfumery.

A pH-dependent ionizable lipid helps nanoparticles escape endosomes, improving nucleic acid uptake while limiting carrier cytotoxicity.

A sulfur-containing 2-phenylbenzotriazole compound steepens absorption from 350 to 420 nm while limiting visible-light absorption.

Replacing hazardous diisocyanates with carbonyldiimidazole and propargylamine supports REACH-compliant NPBA synthesis and easy purification.

A photoactive monomer-derived compound forms cross-links in a low-Tg polymer, improving adhesive strength, holding power, and substrate contamination resistance.

Controlled hydrolysis, coupling, and final condensation create a high-yield P2X3 inhibitor route suited to industrial production.

Photocurable or thermosetting groups help form uniform OLED films that resist solvents after solution processing, including inkjet fabrication.

A tailored odorant compound introduces novel lactonic and green notes with cleaner, fresher aromatic, sage, and lavender impressions.

Segmented oxoisoquinoline synthesis isolates intermediates for higher yield, easier purification, and lower solvent use in industrial production.

Covalently labeling extracellular membrane-protein domains replaces antibody-specific recognition for broader orientation monitoring across cell types.

Azeotropic water removal drives amino acid cyclocondensation, raising N-protected diketopiperazine yield while shortening reaction and purification time.

By tuning capping-layer refractive index with heteroatom-substituted fluorene compounds, OLEDs extract blue, green, and red light more uniformly.

Poor BCR-inhibitor response in MyD88L265P ABC-DLBCL motivates a single oxazole compound that blocks IRAK4 and BTK.

Heteroaryl substitution helps these methacrylic esters resist hydrolysis while activating NRF2 and reducing cytokine release.

The case uses fused nitrogen-containing compounds as OLED hosts or delayed-fluorescent emitters to improve quantum efficiency, color tuning, and stability.

Formula I and II compounds vary substituents to modulate RAS superfamily proteins for cancer, fibrotic, and inflammatory disease treatment.

Novel ionizable cationic lipids improve nucleic acid transfection and release while addressing instability and toxicity in liposomal delivery.

Selective host-factor targeting inhibits coronaviruses and influenza viruses while minimizing host toxicity and viral resistance.

Specific dibenzofuran substituents confine excitons and improve external quantum efficiency while extending organic EL device lifetime.

Combining anthracene and carbazole in one host compound reduces HOMO mismatch to improve hole injection, emission efficiency, and reliability.

Measuring ClpP activity helps identify patients likely to respond to imipridone-like agents and monitor treatment efficacy.

Imbalanced charge transport is addressed by adding nitrogen heterocycles to bicarbazole OLED materials for better stability and efficiency.

Existing HPK1 modulators have limited efficacy and selectivity; tricyclic compounds are designed to enhance antitumor immunity.

Selective THRβ activation supports lipid regulation while limiting unwanted cardiac and thyroid-axis side effects.

A base-mediated benzoannulation of indole-ynones enables regioselective carbazole synthesis and concise routes to named natural products.

Indolocarbazole donors linked to quinazoline or quinoxaline acceptors improve OLED luminous and quantum efficiency while lowering operating voltage.